Cavalry Biosciences
3 known investors
Cavalry Biosciences is a biopharmaceutical company focused on developing medicines that leverage the body's inherent regenerative and repair mechanisms, particularly in areas of age-related disease and tissue regeneration. The company applies translational biology and drug development expertise across multiple therapeutic areas.
BiotechDeep TechLongevityMedical Devices
Founders & leadership
JV
Jan van Deursen, PhDinCo-founder, Advisor
N(
Nathaniel (Ned) David, PhDinCo-founder, Chairman
Investors · 3
In the news
- Cavalry Biosciences pursues $75M Series B to test eye and muscle disorder drugsendpoints.news · 2026
- Team - Mission BioCapitalmissionbiocapital.com · 2021